Prof. Roehrborn talks about a new predictive analytics solution that projects LUTS changes in individual profiles with PBO, DUT, TAM or CT therapy, using baseline characteristics that define the patient risk of disease progression.
Prof. Roehrborn talks about a new predictive analytics solution that projects LUTS changes in individual profiles with PBO, DUT, TAM or CT therapy, using baseline characteristics that define the patient risk of disease progression.